Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma

Hepatocellular carcinoma is a common gastrointestinal malignancy with a high mortality rate and limited treatment options. Molecularly targeted drugs combined with immune checkpoint inhibitors have shown unique advantages over single-agent applications, significantly prolonging patient survival. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Shuqi, Wang, Mengchao, Zeng, Chuanxiu, Ou, Yan, Zhao, Lu, Wang, Dong, Chen, Liwei, Kong, Fanming, Yi, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248438/
https://www.ncbi.nlm.nih.gov/pubmed/37305582
http://dx.doi.org/10.3389/fonc.2023.1197698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248438/
https://www.ncbi.nlm.nih.gov/pubmed/37305582
http://dx.doi.org/10.3389/fonc.2023.1197698

Ejemplares similares